Back to LCTX
GRS Advisors, LLC LCTX Position History
Lineage Cell Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$40.6M
Q3 2026
Peak value
$53M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $53M |
| Q1 2026 | $31.7M |
| Q2 2026 | $34.4M |
| Q3 2026 | $40.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $40.6M | 1.19M | — | — |
| Q2 2026 | $34.4M | 795.9K | — | — |
| Q1 2026 | $31.7M | 966.2K | — | — |
| Q4 2025 | $53M | 1.52M | — | — |
Other funds holding LCTX
$668.6M
$601.9M
$537.7M
$532.4M
$482.3M
$391.7M
$332.9M
$299.1M